BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7301637)

  • 1. Behavioral effects of dynorphin 1-13 in the mouse and rat: initial observations.
    Walker JM; Katz RJ; Akil H
    Peptides; 1980; 1(4):341-5. PubMed ID: 7301637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin-(1-13) induces spontaneous feeding in rats.
    Morley JE; Levine AS
    Life Sci; 1981 Nov; 29(18):1901-3. PubMed ID: 7311723
    [No Abstract]   [Full Text] [Related]  

  • 3. Peptide-induced excessive grooming in the rat: the role of opiate receptors.
    Aloyo VJ; Spruijt B; Zwiers H; Gispen WH
    Peptides; 1983; 4(6):833-6. PubMed ID: 6324139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone reserves the inhibitory effects of dynorphin A on motor activity in the mouse.
    Ukai M; Yamada S; Kameyama T
    Pharmacol Biochem Behav; 1984 May; 20(5):815-8. PubMed ID: 6146145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antagonistic effects of naloxone on hypermotility in mice induced by dynorphin-(1-13) using a multi-dimensional behavioral analysis.
    Ukai M; Kameyama T
    Neuropharmacology; 1984 Feb; 23(2A):165-8. PubMed ID: 6717756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and neurochemical effects of the new opioid peptide dynorphin--(1-13): comparison with other neuropeptides.
    Zwiers H; Aloyo VJ; Gispen WH
    Life Sci; 1981 Jun; 28(22):2545-51. PubMed ID: 6265732
    [No Abstract]   [Full Text] [Related]  

  • 7. Electrophysiological evidence for kappa-agonist activity of dynorphin in rat brain.
    Brookes A; Bradley PB
    Neuropharmacology; 1984 Feb; 23(2A):207-10. PubMed ID: 6325991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.
    Faden AI; Jacobs TP
    Br J Pharmacol; 1984 Feb; 81(2):271-6. PubMed ID: 6142741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects and in vivo degradation of intraventricularly administered dynorphin-(1-13) and D-Ala2-dynorphin-(1-11) in rats.
    Herman BH; Leslie F; Goldstein A
    Life Sci; 1980 Sep; 27(10):883-92. PubMed ID: 7191035
    [No Abstract]   [Full Text] [Related]  

  • 10. Dynorphin-(1-13), dopamine and feeding in rats.
    Morley JE; Levine AS; Grace M; Kneip J
    Pharmacol Biochem Behav; 1982 May; 16(5):701-5. PubMed ID: 6283566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive effect of dynorphin-(1-13) on luteinizing hormone release in conscious castrated rats.
    Kinoshita F; Nakai Y; Katakami H; Imura H
    Life Sci; 1982 May; 30(22):1915-9. PubMed ID: 6287134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
    Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
    Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intracerebroventricular injection of dynorphin, leumorphin and alpha neo-endorphin on operant feeding in pigs.
    Baldwin BA; de la Riva C; Ebenezer IS
    Physiol Behav; 1990 Dec; 48(6):821-4. PubMed ID: 1982360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral effects of dynorphin -- a novel opioid neuropeptide.
    Katz RJ
    Neuropharmacology; 1980 Aug; 19(8):801-3. PubMed ID: 6106908
    [No Abstract]   [Full Text] [Related]  

  • 15. Dynorphin: potent analgesic effect in spinal cord of the rat.
    Han JS; Xie CW
    Sci Sin B; 1984 Feb; 27(2):169-77. PubMed ID: 6147015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-selective opioid peptides fail to affect behavioral responses induced by a low dose of apomorphine in the mouse.
    Ukai M; Toyoshi T; Kameyama T
    Pharmacol Biochem Behav; 1993 Nov; 46(3):587-91. PubMed ID: 7904071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of dynorphin and the kappa opioid receptor in feeding.
    Morley JE; Levine AS
    Peptides; 1983; 4(6):797-800. PubMed ID: 6143298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
    Laurent S; Schmitt H
    Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynorphin A: inhibitory effect on other opiate ligand bindings in the mouse brain.
    Garzón J; Sánchez-Blázquez P; Gerhart J; Loh HH; Lee NM
    Biochem Pharmacol; 1984 Aug; 33(16):2609-14. PubMed ID: 6147144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynorphin inhibition of the neurotensin contractile activity on the myenteric plexus.
    Huidobro-Toro JP; Zhu YX; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1984 Feb; 228(2):293-303. PubMed ID: 6141281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.